Nuvalent (NASDAQ:NUVL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Nuvalent (NUVL) operate in?

Nuvalent is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Nuvalent Stock (NASDAQ: NUVL) stock price, news, charts, stock research, profile.

Open	$87.07
Close	$87.69
Volume / Avg.	387.31K / 520.66K
Day Range	$85.38 - $89.04
52 Wk Range	56.52 - 113.51
Market Cap	$6.23B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	19.34%
Days to Cover	10.5

Recent News

Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?

Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week.

Lekha Gupta

Why Nuvalent (NUVL) Shares Are Down 6% Today

Nuvalent shares are trading lower by 6.2% during Tuesday's session. The company priced a $500 million public offering of 5 million shares at $100 each.

Henry Khederian

Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity

Nuvalent presented updated Phase 1 data from its ARROS-1 and ALKOVE-1 trials at the ESMO Congress 2024. Key data showed promising response rates in pretreated patients, with pivotal results expected in 2025.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$87.07
Close	$87.69
Volume / Avg.	387.31K / 520.66K
Day Range	$85.38 - $89.04
52 Wk Range	56.52 - 113.51
Market Cap	$6.23B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	19.34%
Days to Cover	10.5

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Nuvalent (NUVL) stock?

You can purchase shares of Nuvalent (NASDAQ:NUVL) through any online brokerage.

View our list of the best stock brokerages

Who are Nuvalent (NUVL) competitors?

Other companies in Nuvalent’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS) and Neurocrine Biosciences (NASDAQ:NBIX).

What is the forecast, or price target, for Nuvalent (NUVL) stock?

Nuvalent has a consensus price target of $102.00.

What is the current price for Nuvalent (NUVL)?

The stock price for Nuvalent (NASDAQ: NUVL) is $87.69 last updated November 18, 2024 at 4:00 PM EST.

Does Nuvalent (NUVL) pay a dividend?

There are no upcoming dividends for Nuvalent.

When is Nuvalent (NASDAQ:NUVL) reporting earnings?

Nuvalent’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Nuvalent (NUVL) going to split?

There is no upcoming split for Nuvalent.

What sector and industry does Nuvalent (NUVL) operate in?

Nuvalent is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Nuvalent

Nuvalent (NUVL) Forecast